Over half of patients saw an improvement after being treated with biological therapies for inflammatory bowel disease (IBD). Data from the first national report of biological therapies shows that 62% of adult patients and 73% of paediatric patients saw the severity of their disease decrease after 12 weeks of treatment with biological therapy. IBD affects... Read More

One of the PCSG Digest’s distinguished cover artists, Dr Aruna Mene, Consultant Histopathologist at the Royal Blackburn Hospital, has a solo exhibition of her vibrant fabric collages in Central London this September.The exhibition, which runs from the September 24th to September 27th (10am-6pm) will be at the Nehru Centre, High Commission of India, in South... Read More

The Acute upper gastrointestinal bleeding quality standard has now been published. You can view the quality standard by following this link: Click here

Hyderabad: Scientists from the Centre for Cellular and Molecular Biology (CCMB) and the Asian Institute of Gastroenterology(AIG) here, in collaboration with a group of scientists from abroad, have found a new `gene-association` with the onset of…. Click here

Patients with Crohn’s disease in remission did not experience fewer episodes of relapse when treated with probiotic yeast Saccharomyces boulardii compared with placebo recipients in a recent study. In the double blind, multicenter, prospective … Click here

Despite previous data showing beneficial effects, the probiotic Saccharomuces boulardii (S. boulardii) does not prevent clinical relapse in patients with Crohn’s disease, according to a new study in Clinical Gastroenterology and Hepatology, the … Click here

During a heat wave, patients with IBD should be aware that there is an increased risk for a flare and contact their gastroenterologist in cases of an increase of stool frequency or abdominal pain.” Disclosure: The researchers report no relevant… Click here

Click here to view an interesting article on IBS, written by committee member Mike Cohen.